Indonesia · Delayed Price · Currency is IDR PT Medikaloka Hermina Tbk Statistics
Total Valuation
IDX:HEAL has a market cap or net worth of IDR 23.28 trillion. The enterprise value is 27.17 trillion.
| Market Cap | 23.28T |
| Enterprise Value | 27.17T |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | May 5, 2025 |
Share Statistics
IDX:HEAL has 15.37 billion shares outstanding. The number of shares has increased by 0.52% in one year.
| Current Share Class | 15.37B |
| Shares Outstanding | 15.37B |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | +6.84% |
| Owned by Insiders (%) | 26.11% |
| Owned by Institutions (%) | 6.99% |
| Float | 10.24B |
Valuation Ratios
The trailing PE ratio is 53.64 and the forward PE ratio is 36.25. IDX:HEAL's PEG ratio is 3.33.
| PE Ratio | 53.64 |
| Forward PE | 36.25 |
| PS Ratio | 3.34 |
| PB Ratio | 3.26 |
| P/TBV Ratio | 4.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 22.33 |
| PEG Ratio | 3.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.74, with an EV/FCF ratio of -33.44.
| EV / Earnings | 64.11 |
| EV / Sales | 3.89 |
| EV / EBITDA | 15.74 |
| EV / EBIT | 28.75 |
| EV / FCF | -33.44 |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.62 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 1.92 |
| Debt / FCF | -4.08 |
| Interest Coverage | 4.02 |
Financial Efficiency
Return on equity (ROE) is 8.41% and return on invested capital (ROIC) is 6.14%.
| Return on Equity (ROE) | 8.41% |
| Return on Assets (ROA) | 5.38% |
| Return on Invested Capital (ROIC) | 6.14% |
| Return on Capital Employed (ROCE) | 9.19% |
| Revenue Per Employee | 380.43M |
| Profits Per Employee | 23.10M |
| Employee Count | 17,626 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 39.72 |
Taxes
In the past 12 months, IDX:HEAL has paid 190.63 billion in taxes.
| Income Tax | 190.63B |
| Effective Tax Rate | 25.99% |
Stock Price Statistics
The stock price has increased by +4.93% in the last 52 weeks. The beta is -0.00, so IDX:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | +4.93% |
| 50-Day Moving Average | 1,602.50 |
| 200-Day Moving Average | 1,451.95 |
| Relative Strength Index (RSI) | 36.13 |
| Average Volume (20 Days) | 10,579,605 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:HEAL had revenue of IDR 6.98 trillion and earned 423.80 billion in profits. Earnings per share was 28.24.
| Revenue | 6.98T |
| Gross Profit | 2.17T |
| Operating Income | 945.06B |
| Pretax Income | 733.47B |
| Net Income | 423.80B |
| EBITDA | 1.72T |
| EBIT | 945.06B |
| Earnings Per Share (EPS) | 28.24 |
Balance Sheet
The company has 956.81 billion in cash and 3.32 trillion in debt, giving a net cash position of -2,362.04 billion or -153.72 per share.
| Cash & Cash Equivalents | 956.81B |
| Total Debt | 3.32T |
| Net Cash | -2,362.04B |
| Net Cash Per Share | -153.72 |
| Equity (Book Value) | 7.13T |
| Book Value Per Share | 364.64 |
| Working Capital | 951.18B |
Cash Flow
In the last 12 months, operating cash flow was 1.04 trillion and capital expenditures -1,855.01 billion, giving a free cash flow of -812.51 billion.
| Operating Cash Flow | 1.04T |
| Capital Expenditures | -1,855.01B |
| Free Cash Flow | -812.51B |
| FCF Per Share | -52.88 |
Margins
Gross margin is 31.07%, with operating and profit margins of 13.54% and 6.07%.
| Gross Margin | 31.07% |
| Operating Margin | 13.54% |
| Pretax Margin | 10.51% |
| Profit Margin | 6.07% |
| EBITDA Margin | 24.65% |
| EBIT Margin | 13.54% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.50, which amounts to a dividend yield of 0.70%.
| Dividend Per Share | 10.50 |
| Dividend Yield | 0.70% |
| Dividend Growth (YoY) | 23.53% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 36.69% |
| Buyback Yield | -0.52% |
| Shareholder Yield | 0.18% |
| Earnings Yield | 1.82% |
| FCF Yield | -3.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 30, 2021. It was a forward split with a ratio of 5.
| Last Split Date | Jul 30, 2021 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
IDX:HEAL has an Altman Z-Score of 4.11 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.11 |
| Piotroski F-Score | 5 |